noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

News > Science

related tags Geology Biology Biotechnology Research Space Program Scientific Institutions Scientific and Research Institutes Space Agencies

Results Science

John Boozman

Boozman Joins Britt, Colleagues in Advocating Critical NIH Research Funding

-7h 37m
Codexis Inc.

Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis

-9h 2m
George Mason University

I-Corps in 3D: Streaming toward better telehealth

-9h 10m
PDS Biotechnology Corporation

Statement of Changes in Beneficial Ownership (Form 4)

-9h 11m
PDS Biotechnology Corporation

Statement of Changes in Beneficial Ownership (Form 4)

-9h 11m
Third Harmonic Bio Inc.

Efficacy of THB001, a Potent and Selective Oral Small Molecule Inhibitor of Wild Type KIT Receptor Tyrosine Kinase, in a Rat Passive Cutaneous Anaphylaxis Model

-9h 36m
Third Harmonic Bio Inc.

First-in-human Safety, Pharmacokinetics and Pharmacodynamics of THB001: An Orally Available, Potent and Highly Selective Small Molecule Inhibitor of Wild Type KIT Receptor Tyrosine Kinase

-9h 36m
Third Harmonic Bio Inc.

A Phase 1b, Open-label Study in Patients with Cold Urticaria (ColdU) Using THB001, an Orally Available, Potent and Highly Selective Small Molecule Inhibitor of Wild Type KIT Receptor Tyrosine Kinase

-9h 36m
Third Harmonic Bio Inc.

First-in-human Study of THB335, an Oral Small Molecule Inhibitor of Wild Type KIT Receptor Tyrosine Kinase: Initial Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) Results from Single Ascending and Multiple Ascending Dose Cohorts

-9h 36m
Mitch McConnell

Senator McConnell Joins Colleagues in Advocating for Critical NIH Research Funding

-9h 41m